Exploration of quality criteria for the detection of peak inspiratory flow under different resistance conditions.

BACKGROUND At present, robust quality criteria and methods for the assessment of Peak inspiratory flow meter performance are lacking. OBJECTIVE A standard flow-volume simulator for quality control analyses of an inhalation assessment device was utilized with different simulated resistance levels in order to propose a quality testing method and associated standard for this device type. METHODS A standard flow-volume simulator was utilized to assess the performance of an In-Check DIAL® (Device I) and an intelligent inhalation assessment device (Device P) at a fixed volume and flow rate. Indices used to evaluate these two instruments included repeatability, accuracy, linearity, and impedance. RESULTS Both devices exhibited good repeatability (<± 3 L/min). The difference between test results and standard simulator values for Device P was less than ± 5 L/min at resistance level R1 but higher than ± 5 L/min at resistance levels R2-5, while Device I were greater than 5 L/min at all resistance levels. The relative error for Device P was <± 10% at resistance levels R1, R2, and R4, but > 10% at resistance levels R3 and R5. The relative error values for Device I at all five resistance levels were > 10%. Device P passed the linearity test at the R2 resistance level, while Device I partially passed the linearity test at all five resistance levels. CONCLUSION Standard monitoring methods and standards provide a valuable approach to the more reliable clinical assessment and application of these instruments.

[1]  J. Zhang,et al.  Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma , 2021, BMC Pulmonary Medicine.

[2]  Shahid Shah,et al.  The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature , 2020, Expert review of pharmacoeconomics & outcomes research.

[3]  D. Mahler,et al.  Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers. , 2020, Chest.

[4]  Kevin McCarthy,et al.  Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement , 2019, American journal of respiratory and critical care medicine.

[5]  G. Brusselle,et al.  Prevalence and burden of asthma in China: time to act , 2019, The Lancet.

[6]  Y. Kuo,et al.  Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD. , 2019, Chronic obstructive pulmonary diseases.

[7]  R. Pleasants,et al.  Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD , 2019, International journal of chronic obstructive pulmonary disease.

[8]  D. Price,et al.  Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation , 2018, International journal of chronic obstructive pulmonary disease.

[9]  P. Goyal,et al.  Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial , 2018, BMC Pulmonary Medicine.

[10]  M. Sanders Guiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler Technique , 2017, Pulmonary medicine.

[11]  D. Mahler Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease. , 2017, Annals of the American Thoracic Society.

[12]  P. Pornsuriyasak,et al.  Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases , 2017, Journal of asthma and allergy.

[13]  S. Cassan,et al.  Appropriate use of a dry powder inhaler based on inhalation flow pattern , 2017, Journal of pharmaceutical health care and sciences.

[14]  H. Mansour,et al.  Dry powder inhalers in COPD, lung inflammation and pulmonary infections , 2015, Expert opinion on drug delivery.

[15]  D. Mahler,et al.  Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler. , 2013, Journal of aerosol medicine and pulmonary drug delivery.

[16]  Chris Corrigan,et al.  Inhaler devices - from theory to practice. , 2013, Respiratory medicine.

[17]  I. Clifton,et al.  Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma , 2012, Expert review of respiratory medicine.

[18]  H. Chrystyn,et al.  What the pulmonary specialist should know about the new inhalation therapies , 2011, European Respiratory Journal.

[19]  David Price,et al.  Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. , 2010, Respiratory medicine.

[20]  O. Usmani,et al.  Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .

[21]  U. Cegla Pressure and inspiratory flow characteristics of dry powder inhalers. , 2004, Respiratory medicine.

[22]  J. Palen Peak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL). , 2003 .

[23]  J. Molema,et al.  In Check Dial: accuracy for Diskus and Turbuhaler. , 2003, International journal of pharmaceutics.

[24]  H. Chrystyn,et al.  Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates. , 2003, Respiratory medicine.

[25]  M. Everard,et al.  Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. , 1997, Respiratory medicine.

[26]  G. Scheuch,et al.  The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[27]  R. Schultz,et al.  Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[28]  A. Hollingworth,et al.  The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing. , 1993, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.